泓博医药(301230)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

301230 泓博医药

已收盘 09-18 15:00:00

{"stockData":{"symbol":"301230","market":"SZ","secType":"STK","nameCN":"泓博医药","latestPrice":35.21,"timestamp":1789715037000,"preClose":31.79,"halted":0,"volume":37542597,"delay":0,"changeRate":0.1076,"floatShares":163000000,"shares":181000000,"eps":0.2115,"marketStatus":"已收盘","change":3.42,"latestTime":"09-18 15:00:00","open":32.43,"high":38.15,"low":32.07,"amount":1331000000,"amplitude":0.1913,"askPrice":35.22,"askSize":2,"bidPrice":35.21,"bidSize":97,"shortable":0,"etf":0,"ttmEps":0.2115,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789954200000},"marketStatusCode":5,"adr":0,"adjPreClose":31.79,"symbolType":"stock","openAndCloseTimeList":[[1789695000000,1789702200000],[1789707600000,1789714800000]],"highLimit":34.97,"lowLimit":28.61,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":180941126,"isCdr":false,"pbRate":5.68,"roa":"--","peRate":166.477541,"roe":"2.82%","epsLYR":0.25,"committee":0.632156,"marketValue":6371000000,"turnoverRate":0.2307,"status":0,"floatMarketCap":5730000000},"requestUrl":"/m/hq/s/301230/wiki","defaultTab":"wiki","newsList":[{"id":"2668195329","title":"异动快报：泓博医药（301230）9月18日9点58分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2668195329","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668195329?lang=zh_cn&edition=full","pubTime":"2026-09-18 10:06","pubTimestamp":1789697194,"startTime":"0","endTime":"0","summary":"证券之星9月18日盘中消息，9点58分泓博医药（301230）触及涨停板。其所属行业医疗服务目前上涨。领涨股为泓博医药。该股为基因编辑，AI医疗，减肥药概念热股，当日基因编辑概念上涨3.62%，AI医疗概念上涨3.11%，减肥药概念上涨3.07%。9月17日的资金流向数据方面，主力资金净流出1168.08万元，占总成交额1.96%，游资资金净流入1563.39万元，占总成交额2.63%，散户资金净流出395.31万元，占总成交额0.66%。近5日资金流向一览见下表：泓博医药主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091800008968.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301230"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667560932","title":"9月16日泓博医药涨5.29%，长城消费增值混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2667560932","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667560932?lang=zh_cn&edition=full","pubTime":"2026-09-16 16:46","pubTimestamp":1789548383,"startTime":"0","endTime":"0","summary":"证券之星消息，9月16日泓博医药涨5.29%，收盘报30.83元，换手率7.04%，成交量11.45万手，成交额3.46亿元。重仓泓博医药的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为长城基金的长城消费增值混合A。长城消费增值混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091600026254.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301230","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667659073","title":"9月14日泓博医药涨5.41%，长城消费增值混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2667659073","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667659073?lang=zh_cn&edition=full","pubTime":"2026-09-14 16:42","pubTimestamp":1789375332,"startTime":"0","endTime":"0","summary":"证券之星消息，9月14日泓博医药涨5.41%，收盘报29.81元，换手率7.46%，成交量12.14万手，成交额3.56亿元。重仓泓博医药的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为长城基金的长城消费增值混合A。长城消费增值混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400021235.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301230"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666256605","title":"9月10日泓博医药跌6.14%，长城消费增值混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2666256605","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666256605?lang=zh_cn&edition=full","pubTime":"2026-09-10 16:39","pubTimestamp":1789029575,"startTime":"0","endTime":"0","summary":"证券之星消息，9月10日泓博医药跌6.14%，收盘报29.37元，换手率9.74%，成交量15.85万手，成交额4.7亿元。重仓泓博医药的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为长城基金的长城消费增值混合A。长城消费增值混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091000029233.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301230"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666305190","title":"泓博医药：截至2026年8月31日股东户数为25,166户","url":"https://stock-news.laohu8.com/highlight/detail?id=2666305190","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666305190?lang=zh_cn&edition=full","pubTime":"2026-09-09 08:51","pubTimestamp":1788915112,"startTime":"0","endTime":"0","summary":"证券之星消息，泓博医药(301230)09月08日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司截至8月31日的股东人数情况泓博医药回复：尊敬的投资者您好！根据中登公司下发的股东名册，截至2026年8月31日（交易日），公司的股东户数为25,166户。感谢关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090900007882.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301230","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664400067","title":"股市必读：泓博医药（301230）8月31日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2664400067","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664400067?lang=zh_cn&edition=full","pubTime":"2026-09-01 02:34","pubTimestamp":1788201252,"startTime":"0","endTime":"0","summary":"截至2026年8月31日收盘，泓博医药报收于30.78元，下跌0.55%，换手率6.72%，成交量10.93万手，成交额3.32亿元。董秘最新回复投资者： 成都泓博今年公布了一项核苷酸单体制备工艺专利，请问该工艺的产品是否可以应用于mRNA，也就是信使核糖核酸。交易信息汇总资金流向8月31日主力资金净流入328.53万元，占总成交额0.99%；游资资金净流入31.66万元，占总成交额0.1%；散户资金净流出360.19万元，占总成交额1.08%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100002404.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301230"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663407590","title":"泓博医药：该专利制备的产品可以应用于mRNA的合成","url":"https://stock-news.laohu8.com/highlight/detail?id=2663407590","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663407590?lang=zh_cn&edition=full","pubTime":"2026-08-31 16:39","pubTimestamp":1788165546,"startTime":"0","endTime":"0","summary":"证券之星消息，泓博医药(301230)08月31日在投资者关系平台上答复投资者关心的问题。投资者提问：成都泓博今年公布了一项核苷酸单体制备工艺专利，请问该工艺的产品是否可以应用于mRNA，也就是信使核糖核酸。泓博医药回复：尊敬的投资者您好！该专利制备的产品可以应用于mRNA的合成。感谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100022271.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301230","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662069942","title":"泓博医药（301230）披露2026年半年度报告，8月28日股价下跌5.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662069942","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662069942?lang=zh_cn&edition=full","pubTime":"2026-08-28 18:02","pubTimestamp":1787911346,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，泓博医药报收于30.95元，较前一交易日下跌5.61%，最新总市值为56亿元。该股当日开盘31.9元，最高32.65元，最低30.88元，成交额达4.78亿元，换手率为9.28%。近日，泓博医药披露《2026年半年度报告》。公告显示，公司2026年上半年营业收入为364,406,306.14元，同比增长3.31%；归属于上市公司股东的净利润为28,729,363.74元，同比增长16.02%；扣除非经常性损益后的净利润为6,460,341.64元，同比下降67.95%。经营活动产生的现金流量净额为72,014,809.37元，同比增长82.66%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800042249.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301230","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662660180","title":"泓博医药(301230)8月10日股东户数2.95万户，较上期增加20.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662660180","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662660180?lang=zh_cn&edition=full","pubTime":"2026-08-28 17:57","pubTimestamp":1787911022,"startTime":"0","endTime":"0","summary":"证券之星消息，近日泓博医药披露，截至2026年8月10日公司股东户数为2.95万户，较7月31日增加5096.0户，增幅为20.85%。在医疗服务行业个股中，泓博医药股东户数低于行业平均水平，截至8月10日，医疗服务行业平均股东户数为4.76万户。从股价来看，2026年7月31日至2026年8月10日，泓博医药区间涨幅为43.62%，在此期间股东户数增加5096.0户，增幅为20.85%。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800041824.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301230","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662068532","title":"8月28日泓博医药跌5.61%，长城消费增值混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2662068532","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662068532?lang=zh_cn&edition=full","pubTime":"2026-08-28 16:42","pubTimestamp":1787906534,"startTime":"0","endTime":"0","summary":"证券之星消息，8月28日泓博医药跌5.61%，收盘报30.95元，换手率9.28%，成交量15.1万手，成交额4.78亿元。重仓泓博医药的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为长城基金的长城消费增值混合A。长城消费增值混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800038490.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301230","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662038355","title":"股市必读：泓博医药新发布《第四届董事会第九次会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2662038355","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662038355?lang=zh_cn&edition=full","pubTime":"2026-08-28 04:02","pubTimestamp":1787860939,"startTime":"0","endTime":"0","summary":"截至2026年8月27日收盘，泓博医药报收于32.79元，下跌0.03%，换手率6.8%，成交量11.07万手，成交额3.61亿元。公司公告汇总：董事会审议通过《2026年半年度报告》及其摘要，并因权益分派完成将总股本增至180,941,126股，拟修订公司章程并办理工商变更登记。公司公告汇总：提名黄蔚、武进锋、刘波为第四届董事会独立董事候选人，并决定召开2026年第一次临时股东大会。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800008884.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301230"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661224824","title":"8月24日泓博医药跌5.26%，长城消费增值混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2661224824","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661224824?lang=zh_cn&edition=full","pubTime":"2026-08-24 16:42","pubTimestamp":1787560924,"startTime":"0","endTime":"0","summary":"证券之星消息，8月24日泓博医药跌5.26%，收盘报33.84元，换手率9.25%，成交量15.05万手，成交额5.15亿元。重仓泓博医药的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为长城基金的长城消费增值混合A。长城消费增值混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400022153.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301230","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660449629","title":"8月19日泓博医药跌7.47%，长城消费增值混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2660449629","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660449629?lang=zh_cn&edition=full","pubTime":"2026-08-19 17:15","pubTimestamp":1787130944,"startTime":"0","endTime":"0","summary":"证券之星消息，8月19日泓博医药跌7.47%，收盘报34.2元，换手率10.13%，成交量16.49万手，成交额5.79亿元。重仓泓博医药的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为长城基金的长城消费增值混合A。长城消费增值混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081900029666.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301230","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658799368","title":"泓博医药：截至2026年8月10日股东户数为29,532户","url":"https://stock-news.laohu8.com/highlight/detail?id=2658799368","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658799368?lang=zh_cn&edition=full","pubTime":"2026-08-11 16:27","pubTimestamp":1786436827,"startTime":"0","endTime":"0","summary":"证券之星消息，泓博医药(301230)08月11日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好！请问截止2026年8月 10日公司的股东人数是多少？谢谢！泓博医药回复：尊敬的投资者您好！根据中登公司下发的股东名册，截至2026年8月10日（交易日），公司的股东户数为29,532户。感谢关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100025686.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301230"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658998550","title":"泓博医药：不存在应披露未披露的重大事项","url":"https://stock-news.laohu8.com/highlight/detail?id=2658998550","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658998550?lang=zh_cn&edition=full","pubTime":"2026-08-11 15:45","pubTimestamp":1786434315,"startTime":"0","endTime":"0","summary":"证券之星消息，泓博医药08月11日在投资者关系平台上答复投资者关心的问题。特别是在DiOrion平台商业化、热门赛道订单转化、海外大药企合作等方面？公司目前生产经营一切正常，有序开展，不存在应披露未披露的重大事项。DiOrion平台及各业务进展情况请您留意公司即将披露的定期报告。二级市场股价受多重复杂因素共同影响，存在一定波动性，敬请广大投资者注意投资风险。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100021022.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301230","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658501981","title":"8月10日泓博医药涨8.27%，长城消费增值混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2658501981","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658501981?lang=zh_cn&edition=full","pubTime":"2026-08-10 16:49","pubTimestamp":1786351789,"startTime":"0","endTime":"0","summary":"证券之星消息，8月10日泓博医药涨8.27%，收盘报35.1元，换手率23.6%，成交量38.4万手，成交额13.56亿元。重仓泓博医药的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为长城基金的长城消费增值混合A。长城消费增值混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000021023.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301230","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657616148","title":"8月7日泓博医药涨19.99%，长城消费增值混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2657616148","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657616148?lang=zh_cn&edition=full","pubTime":"2026-08-07 16:50","pubTimestamp":1786092645,"startTime":"0","endTime":"0","summary":"证券之星消息，8月7日泓博医药涨19.99%，收盘报32.42元，换手率15.65%，成交量25.47万手，成交额7.58亿元。重仓泓博医药的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为长城基金的长城消费增值混合A。长城消费增值混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700028238.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301230","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657697557","title":"异动快报：泓博医药（301230）8月7日14点35分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2657697557","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657697557?lang=zh_cn&edition=full","pubTime":"2026-08-07 14:45","pubTimestamp":1786085123,"startTime":"0","endTime":"0","summary":"证券之星8月7日盘中消息，14点35分泓博医药（301230）触及涨停板。其所属行业医疗服务目前上涨。领涨股为博腾股份。该股为基因编辑，减肥药，创新药概念热股，当日基因编辑概念上涨7.16%，减肥药概念上涨6.46%，创新药概念上涨5.99%。8月6日的资金流向数据方面，主力资金净流出931.42万元，占总成交额3.18%，游资资金净流出1174.77万元，占总成交额4.01%，散户资金净流入2106.19万元，占总成交额7.19%。近5日资金流向一览见下表：泓博医药主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700020409.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301230","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656327487","title":"泓博医药(301230)7月31日股东户数2.44万户，较上期减少7.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656327487","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656327487?lang=zh_cn&edition=full","pubTime":"2026-08-03 17:45","pubTimestamp":1785750328,"startTime":"0","endTime":"0","summary":"证券之星消息，近日泓博医药披露，截至2026年7月31日公司股东户数为2.44万户，较7月20日减少2065.0户，减幅为7.79%。在医疗服务行业个股中，泓博医药股东户数低于行业平均水平，截至7月31日，医疗服务行业平均股东户数为4.92万户。从股价来看，2026年7月20日至2026年7月31日，泓博医药区间跌幅为12.43%，在此期间股东户数减少2065.0户，减幅为7.79%。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300024131.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301230"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656293033","title":"泓博医药：截至2026年7月31日股东户数为24,436户","url":"https://stock-news.laohu8.com/highlight/detail?id=2656293033","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656293033?lang=zh_cn&edition=full","pubTime":"2026-08-03 15:37","pubTimestamp":1785742674,"startTime":"0","endTime":"0","summary":"证券之星消息，泓博医药(301230)08月03日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司最新股东人数是多少泓博医药回复：尊敬的投资者您好！根据中登公司下发的股东名册，截至2026年7月31日（交易日），公司的股东户数为24,436户。感谢关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300014973.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301230","BK0216"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1789740985544,"stockEarnings":[{"period":"1week","weight":0.0824},{"period":"1month","weight":-0.1399},{"period":"3month","weight":0.1973},{"period":"6month","weight":0.1466},{"period":"1year","weight":0.1043},{"period":"ytd","weight":0.389}],"compareEarnings":[{"period":"1week","weight":-0.0149},{"period":"1month","weight":-0.0287},{"period":"3month","weight":-0.0525},{"period":"6month","weight":-0.0206},{"period":"1year","weight":-0.0002},{"period":"ytd","weight":-0.0235}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海泓博智源医药股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"25166人(较上一季度减少14.78%)","perCapita":"6466股","listingDate":"2022-11-01","address":"上海市浦东新区庆达路315号23幢","registeredCapital":"18094万元","survey":"　　上海泓博智源医药股份有限公司的主营业务是药物发现、制药工艺的研究开发以及原料药中间体的商业化生产。公司的主要产品是药物发现（CRO）、工艺研究与开发（CRO/CDMO）、商业化生产（含CMO）。","listedPrice":40},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.0","shortVersion":"4.50.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"泓博医药(301230)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供泓博医药(301230)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"泓博医药,301230,泓博医药股票,泓博医药股票老虎,泓博医药股票老虎国际,泓博医药行情,泓博医药股票行情,泓博医药股价,泓博医药股市,泓博医药股票价格,泓博医药股票交易,泓博医药股票购买,泓博医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"泓博医药(301230)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供泓博医药(301230)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}